GLP-1 drugs have already established themselves as a multibillion-dollar market, with companies constantly seeking new opportunities to stay ahead of…
Browsing: Obesity
Pfizer Makes Bold Move into Obesity Market with $4.9 Billion Metsera Acquisition Pfizer is making waves in the pharmaceutical world…
Credit: Pixabay/CC0 Public Domain It is possible to be “fat but fit,” new research presented at the annual meeting of…
Novo Nordisk’s obesity drug Wegovy has received approval from the U.S. Food and Drug Administration to treat metabolic dysfunction-associated steatohepatitis…
Obesity contributes to multiple diseases and conditions. Effective GLP-1 medications can lead to weight loss. However, their coverage by insurers,…
Roche’s ambitions to make a mark in the competitive obesity market continue to grow. Earlier this year, the pharmaceutical giant…
The United States has recently retracted its commitment to funding early research at the National Institutes of Health. Despite this…
As we approach the midpoint of July, it’s hard to believe how quickly time is flying by. With each passing…
Food Deserts and Their Impact on Health Outcomes: A Detailed Study For years, health experts have been raising concerns about…
Children who experience undernutrition may benefit from weight gain during their first decade of life, leading to taller adults without…
